当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 202011
编号:13839403
丹栀逍遥散加减联合艾司唑仑治疗糖尿病合并失眠临床观察(1)
http://www.100md.com 2020年6月1日 《糖尿病新世界》 202011
     [摘要] 目的 探讨对糖尿病合并失眠患者应用中药丹栀逍遥散加减联合艾司唑仑的治疗效果。方法 选取2017年9月—2019年9月于该院就诊的糖尿病合并失眠患者64例,将其随机分为对照组与研究组,各32例,对照组单纯给予艾司唑仑进行治疗,研究组在对照组基础上联合应用丹栀逍遥散加减加减,连续用药4周后停药1周,比较两组疗效及睡眠质量。结果 研究组临床治愈率37.5%,高于对照组9.4%;总有效率93.8%,高于对照组71.9%,差异有统计学意义(P<0.05)。结论 丹栀逍遥散加减联合艾司唑仑较单纯应用艾司唑仑可显著提高糖尿病合并失眠患者治疗效果,改善患者睡眠治疗。

    [关键词] 丹栀逍遥散;艾司唑仑;糖尿病;失眠

    [中图分类号] R587.2 [文献标识码] A [文章编号] 1672-4062(2020)06(a)-0059-03

    [Abstract] Objective To explore the therapeutic effect of applying Chinese medicine Danzhi Xiaoyao powder combined with estazolam to diabetic patients with insomnia. Methods 64 patients with diabetes mellitus and insomnia who were treated in the hospital from September 2017 to September 2019 were selected and randomly divided into a control group and a study group of 32 cases each. The control group was given eszolen for treatment only. The study group combined with Danzhi Xiaoyao powder addition and subtraction on the basis of the control group. After 4 weeks of continuous medication ......
1 2下一页

您现在查看是摘要页,全文长 3199 字符